4.6 Review

TLRs Go Linear - On the Ubiquitin Edge

Journal

TRENDS IN MOLECULAR MEDICINE
Volume 23, Issue 4, Pages 296-309

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2017.02.003

Keywords

-

Funding

  1. Wellcome Trust [096831/Z/11/Z]
  2. European Research Council [294880]
  3. Boehringer Ingelheim Fonds
  4. Wellcome Trust [096831/Z/11/Z] Funding Source: Wellcome Trust
  5. European Research Council (ERC) [294880] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Toll-like receptors (TLRs) are crucial in protecting the host from pathogens. However, their exact role in disease remains incompletely understood. TLR signaling is tightly controlled because too little or too much TLR activation can result in immunodeficiency or autoinflammation, respectively. There is increasing evidence that linear ubiquitination, mediated by the linear ubiquitin chain assembly complex (LUBAC), plays a pivotal role in the regulation of TLR signaling. Recent advances have identified an intricate interaction between LUBAC and TLRs, with immunological consequences for infection and the development of autoinflammation in the host. We propose that defective linear ubiquitination contributes to TLR-mediated disease pathogenesis and that perturbed TLR signaling contributes to the phenotype observed in inherited LUBAC deficiency in humans and mice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available